With Every Cure, ARPA-H has found a new funding niche

Every Cure is different from other repurposing initiatives because it isn’t focused on a specific disease or drug, and because it plans to run trials in the hope that the results will change practice. The non-profit says it needs government funding to do this because it wants to repurpose drugs to treat diseases that may not be of interest to industry or philanthropic organizations.

The Advanced Research Projects Agency for Health (ARPA-H) announced on Feb. 28 that it had awarded a three-year, $48.3 million contract to Every Cure, which repurposes FDA-approved drugs for diseases lacking treatments...